Brilitas Pharmaceuticals EU OÜ
CopyRegistry data
Legal status
Company ID
16618699VAT code
EE102712474Registered
22/11/2022Share capital
65,000.00 €Contacts
Company registration address
Website
-
A
HighestReliability
A - Highest
0 ** during past year
Number of employees
1Credit limit
No data availableCredit report
Company's financial performance and creditability assessment.0 ** during past year
Taxes
242Debts
-0 ** during past year
Taxable turnover
0
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Data is only provided to registered users with a legitimate interest. |
Financial ratios
Net Profit (€)
Enjoy unlimited use
with Freemium unlimited
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedNet Profit (€)
Register and
explore Okredo dataEBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| 2023 |
|---|
| 0 |
| - |
| -1,451 |
| -1,451 |
| - |
| - |
| 0.00 |
| - |
| -2,902 |
| - |
| -2,902 |
| - |
| - |
| -1,451 |
| 0 |
| 0 |
| 114 |
| 2024 |
|---|
| 24,000 |
| - |
| 15,854 |
| 15,854 |
| - |
| 1.25 |
| 0.00 |
| 126.80 |
| 30,433 |
| 126.80 |
| 30,433 |
| 100.00 |
| 66.06 |
| 34,339 |
| 0 |
| 4,415 |
| 29,924 |
| 2024 |
|---|
| 24,000 |
| - |
| 15,854 |
| 15,854 |
| - |
| 1.25 |
| 0.00 |
| 126.80 |
| 30,433 |
| 126.80 |
| 30,433 |
| 100.00 |
| 66.06 |
| 34,339 |
| 0 |
| 4,415 |
| 29,924 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
Enjoy unlimited use
with Freemium unlimitedCredit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Example report (PDF)
Similar companies
Category:
All other professional, scientific and technical activities n.e.c.Comp. code:
80649631Reg. date:
02/01/2025Turnover:
-No. of employees:
2Category:
All other professional, scientific and technical activities n.e.c.Comp. code:
17135655Reg. date:
16/12/2024Turnover:
-No. of employees:
2Category:
All other professional, scientific and technical activities n.e.c.Comp. code:
17082261Reg. date:
02/10/2024Turnover:
-No. of employees:
1Category:
All other professional, scientific and technical activities n.e.c.Comp. code:
17077165Reg. date:
25/09/2024Turnover:
-No. of employees:
1Category:
All other professional, scientific and technical activities n.e.c.Comp. code:
17064754Reg. date:
09/09/2024Turnover:
-No. of employees:
1Frequently Asked Questions
What is the current status of Brilitas Pharmaceuticals EU OÜ?
Brilitas Pharmaceuticals EU OÜ is currently Registered. It was registered on 22/11/2022.
Where is Brilitas Pharmaceuticals EU OÜ located?
Brilitas Pharmaceuticals EU OÜ is registered at Harju maakond, Tallinn, Kesklinna linnaosa, Pärnu mnt 110.
What does Brilitas Pharmaceuticals EU OÜ do?
Brilitas Pharmaceuticals EU OÜ operates in the All other professional, scientific and technical activities n.e.c. (74991 - EMTAK 2025) sector.
How many employees does Brilitas Pharmaceuticals EU OÜ have?
Brilitas Pharmaceuticals EU OÜ had 1 employees in 2024 II.
What is the annual turnover of Brilitas Pharmaceuticals EU OÜ?
Brilitas Pharmaceuticals EU OÜ reported a turnover of 24,000 EUR in 2024.
What is the net profit of Brilitas Pharmaceuticals EU OÜ?
Brilitas Pharmaceuticals EU OÜ reported a net profit of 15,854 EUR in 2024.
Is Brilitas Pharmaceuticals EU OÜ a reliable company?
Brilitas Pharmaceuticals EU OÜ Pre-Score* rating is A, which indicates the highest level of reliability.
* The credit score is calculated based on financial data, payment history, and other risk indicators.Does Brilitas Pharmaceuticals EU OÜ have any unpaid debts?
Brilitas Pharmaceuticals EU OÜ has no recorded unpaid debts.